The first part of the article below is by Bottini and Bottini from marketwatch.com.
SAN DIEGO, Dec. 17, 2014 /PRNewswire/ — BOTTINI & BOTTINI, INC. (http://www.bottinilaw.com) today announced that a class action has been commenced in the United States District Court for the Central District of California on behalf of persons who sold Allergan, Inc. AGN, +0.86% common stock between February 25, 2014 and April 21, 2014 (the “Class Period”).
If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from December 17, 2014. If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s counsel, Frank A. Bottini or Albert Y. Chang of Bottini & Bottini, at (858) 914-2001, or via e-mail at email@example.com or firstname.lastname@example.org. If you are a member of this class, you can view a copy of the complaint as filed or join this class action online at http://www.bottinilaw.com/cases/ valeant/. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
Stay Connected with Marc Primo Pulisci